Bexson Biomedical
Ketamine and wearable device for post-operative pain.
Launch date
Employees
Market cap
-
Enterprise valuation
€17—26m (Dealroom.co estimates Feb 2021.)
Santa Barbara California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$4.8m | Series A | ||
| Total Funding | €4.4m | ||